Early Palliative Care Team Support for Metastatic Cancer Patients Hospitalized Unexpectedly
Tests adding palliative care early for adults with advanced cancer admitted unexpectedly.
Plain-language title generated from the registry record
Registry title: Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic Cancer
Key facts
- Where
- Lille, FranceSee the site
Where in France
- Centre Oscar LambretLille, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Oscar Lambret
- Trial code
- NCT07490106
- Record updated
- 17 September 2026
- Original description
This is a multicenter, national, interventional, cluster-randomized study, "stepped wedge" design. This study includes patients with metastatic or locally advanced digestive, gynecological, ENT, or sarcoma cancer, currently undergoing systemic palliative treatment and hospitalized on an unscheduled basis. The study will aim to evaluate the impact of early palliative care implementation for patients with metastatic or advanced cancer identified during an unplanned hospitalization.Read full original descriptionShow less
Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic Cancer
This is a multicenter, national, interventional, cluster-randomized study, "stepped wedge" design. This study includes patients with metastatic or locally advanced digestive, gynecological, ENT, or sarcoma cancer, currently undergoing systemic palliative treatment and hospitalized on an unscheduled basis. The study will aim to evaluate the impact of early palliative care implementation for patients with metastatic or advanced cancer identified during an unplanned hospitalization.
Inclusion: Subjects aged 18 years and older; Diagnosed with metastatic or locally advanced digestive, gynecological, ENT, or sarcoma cancer; Currently undergoing systemic palliative treatment (no prospect of cure); Hospitalized on an unscheduled basis (i.e., unplanned hospitalization for scheduled oncology treatments); Patient covered by the French social security system; Informed consent, written and signed.
Exclusion: Patient receiving end-of-life care; PS (WHO) = 4; Patient opposed to the use of medical data for research purposes; Person deprived of liberty or under guardianship; Inability to undergo medical monitoring for the trial for geographical, social, or psychological reasons.